Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage ...
Sarepta price target lowered to $75 from $80 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Sarepta (SRPT) to $75 from $80 and keeps a Sell rating on the shares. Sarepta’s deal to ...
bovnews10d
H.C. Wainwright Issues Neutral Rating for Ardelyx Inc (ARDX) Stock
H.C. Wainwright has recently reduced Ardelyx Inc (ARDX) stock to Neutral rating, as announced on November 11, 2024, according to Finviz. Earlier, on July 2, 2024, Piper Sandler had reduced the stock ...
bovnews8h
Why Did H.C. Wainwright Give Energy Fuels Inc (UUUU) Stock Buy Rating?
On Friday, Energy Fuels Inc (UUUU) stock saw a modest uptick, ending the day at $7.29 which represents a slight increase of $0.49 or 7.21% from the prior close of $6.8. The stock opened at $7.1 and ...
Splash Beverage price target lowered to 50c from $1 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Splash Beverage (SBEV) to 50c from $1 and keeps a Buy rating on the shares ...
Promising Prospects for Cytokinetics: Aficamten’s Strong Phase 3 Results and Strategic Bayer Collaboration Drive Buy Rating
H.C. Wainwright analyst Joseph Pantginis has reiterated their bullish stance on CYTK stock, giving a Buy rating on November 25.Don't Miss our ...
ETF Daily News1d
electroCore, Inc. Enters into At The Market Offering Agreement with H.C. Wainwright & Co., LLC
The Company clarified that they are not obligated to sell any Shares under this agreement. H.C. Wainwright & Co., LLC will act to sell the Shares based on electroCore’s instructions and within the ...
Investing3d
H.C. Wainwright reiterates Neutral on Agenus stock, focus on bot/bal in colorectal cancer
On Friday, H.C. Wainwright maintained a Neutral rating and a $7.00 price target on Agenus Inc . (NASDAQ:AGEN), a biotechnology company currently valued at approximately $82 million. According to ...
Investing3d
H.C. Wainwright reiterates Buy on IceCure Medical stock, FDA decision on ProSense expected soon
as recommended by H.C. Wainwright. According to InvestingPro analysis, the stock appears undervalued at its current trading level. The reaffirmation came after IceCure Medical announced its third ...
Financial Post6d
Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
today announced that the Company will participate in the virtual H.C Wainwright @ Home fireside chat series taking place on Tuesday, December 3, 2024 at 11:00 am ET. We apologize, but this video has ...
Nasdaq6d
Poseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Arthur He downgraded Poseida Therapeutics (PSTX) to Neutral from Buy with a price target of $9, down from $20, after Roche (RHHBY) agreed to acquire the company for $1.5B ...
Nasdaq6d
Viking’s VK2735 outpacing Amgen’s MariTide, says H.C. Wainwright
After Amgen (AMGN) announced topline data from its Phase 2 study of MariTide, the company’s subcutaneously administered GLP-1 weight loss drug, H.C. Wainwright contends that Viking Therapeutics ...